← 홈

대장·직결장암

255개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 255개
AntibodystaleKahr Bio Australia Pty LtdPhase 2

atezolizumab (Tecentriq, DSP107 + Atezolizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
ADCBiologicstaleRemeGenApproved

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin Combined With Fruquintinib)

HER2; Colorectal Cancer · HER2

#HER2#ADC#Approved#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
AntibodystaleAmsterdam UMC, location VUmcPhase 2

Dose escalation cetuximab (Dose escalation cetuximab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleUniversitaire Ziekenhuizen KU L…Phase 2

Dose escalation of cetuximab (Dose escalation of cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleQilu Hospital of Shandong Unive…Preclinical

Doublet or triplet chemotherapy combined with cetuximab (Doublet or triplet chemotherapy combined with cetuximab)

Colon Cancer · Colon Cancer

#ColonCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleInnovent Biopharmaceutical Tech…Phase 1

Drug: IBI3028 (Drug: IBI3028)

Solid Tumor; Colorectal Cancer · Solid Tumor

#SolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Drug: XS-03, Biological: Bevacizumab, Drug: FOLFOX, Drug: FOLFIRI (Drug: XS-03, Biological: Bevacizumab, Drug: FOLFOX, Drug: FOLFIRI)

Colorectal Cancer; Metastatic Colorectal Cancer With RAS Mutation · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab, Tremelimumab and ,FOLFOX)

Colorectal Cancer Metastatic · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleMedImmune LLCPhase 2

durvalumab (Imfinzi, E1 - mFOLFOX and durvalumab)

Microsatellite-stable Colorectal Cancer · Microsatellite-stable Colorectal Cancer

#Microsatellite-stableColorectalC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleMedImmune LLCPhase 2

durvalumab (Imfinzi, E2 - mFOLFOX6, durvalumab and oleclumab)

Microsatellite-stable Colorectal Cancer · Microsatellite-stable Colorectal Cancer

#Microsatellite-stableColorectalC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleMedImmune LLCPhase 2

durvalumab (Imfinzi, E3 - mFOLFOX6, durvalumab and monalizumab)

Microsatellite-stable Colorectal Cancer · Microsatellite-stable Colorectal Cancer

#Microsatellite-stableColorectalC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
CGTBiologicstaleBeijing BiotechPhase 2

EB-DUO-CAR-NK-CEA/GCC (EB-DUO-CAR-NK-CEA/GCC)

Colorectal Cancer; Metastatic Colorectal Adenocarcinoma · CEA

#CEA#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleZhejiang UniversityPhase 1

EPCAM CAR-T (EPCAM CAR-T)

Advanced Hepatocellular Carcinoma; Advanced Colorectal Cancer · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

EZN-2208, Cetuximab and Irinotecan (EZN-2208, Cetuximab and Irinotecan)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Encorafenib Oral Capsule + Cetuximab (Encorafenib Oral Capsule + Cetuximab)

Colorectal Cancer; BRAF V600E Mutation Positive · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleMassachusetts General HospitalPhase 3

Encorafenib/Binimetinib/Cetuximab Protocol (Encorafenib/Binimetinib/Cetuximab Protocol)

Metastatic Colon Cancer; Stage III Colon Cancer · Metastatic Colon Cancer

#MetastaticColonCancer#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
CGTBiologicstaleM.D. Anderson Cancer CenterPhase 1

Expanded CB-NK cells (Expanded CB-NK cells)

Colon Cancer; Resected Stage · Colon Cancer

#ColonCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleBristol Myers SquibbPhase 1

nivolumab (Opdivo, Experimental: COLONYVAQ-CRC + mFOLFOX6 or CAPOX + Nivolumab)

Colorectal Cancer Metastatic; Colorectal Cancer Stage III · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 3

Experimental: mXELOX plus cetuximab (Experimental: mXELOX plus cetuximab)

Colo-rectal Cancer · Colo-rectal Cancer

#Colo-rectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleUTC Therapeutics Inc.Phase 1

FAST LACO-Stim CDH17 CAR-T (FAST LACO-Stim CDH17 CAR-T)

Biliary Tract Cancer; Colorectal Carcinoma · Biliary Tract Cancer

#BiliaryTractCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING

8 / 13 페이지

← 이전다음 →